IMMUTEP LIMITED — Director's Dealing 2010

Aug 10, 2010

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

	PRIMA BIOMED LIMITED (ASX: PRR)
Name of Entity:
	90 009 237 889
ABN:

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Mr Albert Wong Date of Last Notice: 30 April 2010

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or Indirect Interest		Indirect	Indirect
Nature of Indirect Interest(including registered holder) Note: Provide details of the circumstances giving rise to the relevantinterest.		Director related entity
Date of change		11 August 2010
No. of securities held prior to change				Options-400,000400,000
			Shares	Options
		Direct	-	-
		Indirect	1,600,000	400,000
		Total	1,600,000	400,000
Class		a)Fully Paid Ordinary Shares (PRR)b)Listed Options (PRRO)
Number Acquired				Options---
			Shares	Options
		Direct	-	-
		Indirect	400,000	-
		Total	400,000	-

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

Number Disposed				Shares	Options
		Direct		-	-
		Indirect		-	400,000
		Total		-	400,000
Value/Consideration	$8,000.00
Note: If consideration is non-cash, provide details and estimated
valuation
No. of Securities Held After Change				Shares	Options
		Direct		-	-
		Indirect		2,000,000	-
		Total		2,000,000	-
Nature of Change
Example: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Exercise of PRRO			Options

Part 2 – Change of Director’s Interests in Contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of Contract
Nature of Interest
Name of Registered Holder
(if issued securities)
Date of Change
No. and Class of Securities to
Which Interest Related Prior to
Change
Note: Details are only required for a contract in relation to
which the interest has changed
Interest Acquired
Interest Disposed
Value/Consideration
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest After Change

==> picture [41 x 25] intentionally omitted <==

The CFO Solution

11.8.2010

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002